efavirenz has been researched along with Hepatitis B Virus Infection in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Chandiwana, P; Duri, K; Gumbo, FZ; Marere, T; Mataramvura, H; Mazengera, LR; Mazhandu, AJ; Munjoma, PT | 1 |
| Cai, WP; Deng, XZ; Hu, FY; Lan, Y; Li, F; Li, LH; Nie, Y | 1 |
| Chen, X; Fairley, CK; He, J; Jing, J; Mao, L; Sasadeusz, J; Su, S; Wei, X; Zeng, H; Zhang, L | 1 |
| Choun, K; De Weggheleire, A; Lynen, L; Phirum, L; Thai, S; van Griensven, J | 1 |
| Chi, BH; Chilengi, R; Davies, MA; Egger, M; Hoffmann, CJ; Mulenga, LB; Saag, MS; Sinkala, E; Vinikoor, MJ; Wandeler, G; Zyambo, Z | 1 |
| Amin, J; Avihingsanon, A; Bowden, S; Cooper, DA; Dore, GJ; Lewin, SR; Locarnini, S; Marks, P; Matthews, GV; Petcharapirat, P; Rerknimitr, R; Ruxrungtham, K; Sasadeusz, J | 1 |
| Harvey, C; Leavitt, R; Nguyen, BY; Rockstroh, J; Sklar, P; Strohmaier, K; Teppler, H; Zhao, J | 1 |
| Amaya, G; Arns da Cunha, C; Boven, K; Buelens, A; Clumeck, N; Jayaweera, D; Junod, P; Li, T; Nelson, M; Stevens, M; Tebas, P; Vanveggel, S | 1 |
| Pulido, F; Torralba, M | 1 |
| Boyd, MA; Cooper, DA; Dore, GJ; Duncombe, CJ; Lange, JM; Law, WP; Mahanontharit, A; Phanuphak, P; Ruxrungtham, K | 1 |
| Abo, Y; Anglaret, X; Anzian, A; Chenal, H; Danel, C; Eholié, S; Gabillard, D; Guehi, C; Moh, R; Rouet, F; Sorho, S | 1 |
| Easley, KA; Lennox, JL; Lu, C; Ofotokun, I; Smithson, SE | 1 |
| Chaisson, RE; Mehta, SH; Moore, RD; Sulkowski, MS; Thomas, DL | 1 |
1 review(s) available for efavirenz and Hepatitis B Virus Infection
| Article | Year |
|---|---|
NNRTI hepatotoxicity: efavirenz versus nevirapine.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Chemical and Drug Induced Liver Injury; Cyclopropanes; Hepatitis B; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Liver Diseases; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors | 2002 |
4 trial(s) available for efavirenz and Hepatitis B Virus Infection
| Article | Year |
|---|---|
A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; DNA, Viral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prospective Studies; Tenofovir; Thailand; Treatment Outcome; Zidovudine | 2008 |
Safety and efficacy of raltegravir in patients with HIV-1 and hepatitis B and/or C virus coinfection.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Coinfection; Cyclopropanes; Double-Blind Method; Female; Hepatitis B; Hepatitis C; HIV Infections; HIV-1; Humans; Male; Pyrrolidinones; Raltegravir Potassium; Treatment Outcome | 2012 |
Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Alkynes; Animals; Antiviral Agents; Aspartate Aminotransferases; Benzoxazines; Coinfection; Cyclopropanes; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C; Hepatitis C Antibodies; HIV Infections; HIV-1; Humans; Liver; Liver Function Tests; Male; Middle Aged; Nitriles; Placebos; Pyrimidines; Rilpivirine; Treatment Outcome; Young Adult | 2012 |
Tolerance and acceptability of an efavirenz-based regimen in 740 adults (predominantly women) in West Africa.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cohort Studies; Contraception; Cote d'Ivoire; Cyclopropanes; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; HIV Infections; HIV-1; HIV-2; Humans; Male; Nervous System Diseases; Oxazines; Pregnancy; Pregnancy Complications; Transaminases; Treatment Outcome | 2006 |
8 other study(ies) available for efavirenz and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting.
Topics: Child; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Mothers; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Risk Factors; Seroepidemiologic Studies; Tenofovir | 2023 |
Assessing the association between platelets and immune recovery in HIV/HBV co-infected patients: A long-term cohort in Asia.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Blood Platelets; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Cohort Studies; Cyclopropanes; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Immune Reconstitution; Lamivudine; Longitudinal Studies; Male; Platelet Count; Retrospective Studies; Tenofovir | 2020 |
HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Cohort Studies; Coinfection; Cyclopropanes; Female; Hepatitis B; Hepatitis C; HIV; HIV Infections; Humans; Male; Middle Aged; Nevirapine; Retrospective Studies; Treatment Outcome; Viral Load; Zidovudine | 2018 |
Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia.
Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cambodia; CD4 Lymphocyte Count; Coinfection; Cyclopropanes; Female; Hepatitis B; Hepatitis C; HIV Infections; Humans; Kaplan-Meier Estimate; Lamivudine; Liver; Logistic Models; Male; Middle Aged; Nevirapine; Proportional Hazards Models; Retrospective Studies; Stavudine; Treatment Outcome; Zidovudine | 2014 |
Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Coinfection; Cyclopropanes; Elasticity Imaging Techniques; Emtricitabine; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Liver; Liver Cirrhosis; Logistic Models; Male; Prospective Studies; Viral Load; Zambia | 2017 |
Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001.
Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Chemical and Drug Induced Liver Injury; Cyclopropanes; Female; Hepatitis B; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Incidence; Liver; Liver Diseases; Male; Nevirapine; Oxazines; Prevalence; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Risk Factors; Thailand | 2003 |
Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy.
Topics: Adult; Alanine Transaminase; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Aspartate Aminotransferases; Benzoxazines; CD4-Positive T-Lymphocytes; Cyclopropanes; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis C; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Linear Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Stavudine; Zidovudine | 2007 |
Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.
Topics: Adult; Alanine Transaminase; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Aspartate Aminotransferases; Benzoxazines; Bilirubin; Chemical and Drug Induced Liver Injury; Cyclopropanes; Female; Hepatitis B; Hepatitis C; HIV Infections; Humans; Liver Diseases; Male; Nevirapine; Oxazines; Prospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Treatment Outcome | 2002 |